Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 132 citing Ciulla: Diabetic retinopathy and diabetic macular edema. (0.09 sec) 

A pilot study of multiple intravitreal injections of ranibizumab in patients with center- …


DW Chun, JS Heier, TM Topping, JS Duker, … - Ophthalmology, 2006 - Elsevier
Cited by 118 - Related articles - All 4 versions

A prospective study of serum lipids and risk of diabetic macular edema in type 1 diabetes

- diabetesjournals.org
B Miljanovic, RJ Glynn, DM Nathan, JAE … - Diabetes, 2004 - Am Diabetes Assoc
We evaluated the relationships between serum lipid levels and clinically
significant macular edema (CSME), hard exudates, and other diabetic retinopathy
(DR) end points in a population with type 1 diabetes. We studied data from ...
Cited by 42 - Related articles - BL Direct - All 4 versions

Functional VEGF C-634G polymorphism is associated with development of diabetic macular …


T Awata, S Kurihara, N Takata, T Neda, H … - Biochemical and Biophysical Research …, 2005 - Elsevier
Since vascular endothelial growth factor (VEGF) has a strong effect on induction
of vascular permeability, VEGF is an attractive candidate gene for development
of diabetic macular edema (ME). Among the 378 patients with type 2 diabetes ...
Cited by 39 - Related articles - All 4 versions

Tumor necrosis factor antagonists: preliminary evidence for an emerging approach in the …


PG THEODOSSIADIS, NN MARKOMICHELAKIS … - Retina, 2007 - journals.lww.com
The anti-tumor necrosis factor (TNF) monoclonal antibody infliximab and the
soluble TNF receptor etanercept inhibit the pleiotropic actions of TNF and are
widely used for the treatment of rheumatoid arthritis (RA), juvenile ...
Cited by 33 - Related articles - BL Direct - All 6 versions

Optical coherence tomography: a key to the future management of patients with diabetic …


P Massin, A Girach, A Erginay, A Gaudric - Acta Ophthalmologica Scandinavica, 2006 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ...
Cited by 31 - Related articles - BL Direct - All 3 versions

Endothelial nitric oxide synthase gene is associated with diabetic macular edema in type 2 …

- diabetesjournals.org
T Awata, T Neda, H Iizuka, S Kurihara, T … - Diabetes Care, 2004 - Am Diabetes Assoc
RESULTS—Close linkage disequilibrium was observed between the T-786C
polymorphism and the 27-bp repeat, as has been previously reported, but
Glu298Asp was not in linkage disequilibrium with the other two ...
Cited by 30 - Related articles - BL Direct - All 6 versions

Local multifocal oscillatory potential abnormalities in diabetes and early diabetic retinopathy

- iovs.org
MA Bearse Jr, Y Han, ME Schneck, S Barez, … - Investigative ophthalmology & visual science, 2004 - ARVO
METHODS. One eye of each of 26 normal subjects, 16 diabetic subjects without
retinopathy (NoR), and 16 diabetic subjects with early NPDR was examined.
Slow-flash multifocal electroretinograms (sf-mfERGs) were recorded from the ...
Cited by 27 - Related articles - BL Direct - All 4 versions

Erythropoietin is expressed in the human retina and it is highly elevated in the vitreous fluid …


C Hernandez, A Fonollosa, M Garcia-Ramirez, … - Diabetes care, 2006 - Am Diabetes Assoc
OBJECTIVE—Erythropoietin has been recently found to be increased in the
vitreous fluid from ischemic retinal diseases such as proliferative diabetic
retinopathy (PDR). The aims of the present study were 1) to measure ...
Cited by 25 - Related articles - BL Direct - All 6 versions

Retinal vascular changes in pre-diabetes and prehypertension


TT Nguyen, JJ Wang, TY Wong - Diabetes Care, 2007 - Am Diabetes Assoc
The retinal vasculature can be viewed directly and noninvasively, offering a
unique and easily accessible “window” to study the health and disease of the
human microcirculation in vivo. In the last decade, advances in digital ...
Cited by 26 - Related articles - All 4 versions

Anti-VEGF aptamer (pegaptanib) therapy for ocular vascular diseases


EW Ng, AP Adamis - ANNALS-NEW YORK ACADEMY OF SCIENCES, 2006 - interscience.wiley.com
Abstract: Vascular endothelial growth factor (VEGF) is a central regulator of
both physiological and pathological angiogenesis. Pegaptanib, a 28-nucleotide
RNA aptamer specific for the VEGF 165 isoform, binds to it in the ...
Cited by 24 - Related articles - BL Direct - All 6 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google